Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

6.28
-0.2400-3.68%
Post-market: 6.350.0700+1.11%18:52 EDT
Volume:7.98M
Turnover:50.21M
Market Cap:2.21B
PE:-14.32
High:6.45
Open:6.44
Low:6.17
Close:6.52
52wk High:9.75
52wk Low:2.99
Shares:351.12M
Float Shares:264.00M
Volume Ratio:2.08
T/O Rate:3.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:8.69
PE(LYR):-10.47

Loading ...

Nuvation Bio CEO, CFO to Present at Citi Biopharma Conference Fireside Chat

Reuters
·
Sep 03

Nuvation Bio CSO Gary Hattersley Disposes of Class a Common Shares Worth $709,240

Reuters
·
Aug 22

Cantor Fitzgerald Initiates Nuvation Bio at Overweight

MT Newswires Live
·
Aug 21

Nuvation Bio Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 21

Nuvation Bio initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
Aug 21

Nuvation Bio Wins FDA Fast-Track Status for Safusidenib in IDH1-Mutant Glioma

Reuters
·
Aug 20

Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of Idh1-Mutant Glioma

THOMSON REUTERS
·
Aug 20

Nuvation Bio Inc. : JP Morgan Initiates Coverage with Overweight Rating; Target Price $13

THOMSON REUTERS
·
Aug 18

Power Solutions International And 2 More Growth Stocks With Strong Insider Ownership

Simply Wall St.
·
Aug 11

RBC Adjusts PT on Nuvation Bio to $20 From $19, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), Haemonetics (HAE) and Nuvation Bio (NUVB)

TIPRANKS
·
Aug 07

Nuvation Bio Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Nuvation Bio Posts Corporate Presentation Highlighting Ibtrozi ROS1 Lung Cancer Franchise

Reuters
·
Aug 06

Earnings Flash (NUVB) Nuvation Bio Posts Q2 Net Loss of $0.18 per Share, vs. FactSet Est of $0.15 Loss

MT Newswires Live
·
Aug 06

Nuvation Bio Q2 Revenue Beats Estimates on Ibtrozi Growth

Reuters
·
Aug 06

Nuvation Bio Shares Down 2.4% Premarket After Q2 Results

THOMSON REUTERS
·
Aug 06

Nuvation Bio Q2 Income from Pperations USD -51.036 Million

THOMSON REUTERS
·
Aug 06

Nuvation Bio Q2 Revenue USD 31.687 Million VS. Ibes Estimate USD 27.5 Million

THOMSON REUTERS
·
Aug 06

Nuvation Bio Q2 EPS USD -0.18

THOMSON REUTERS
·
Aug 06

Press Release: Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 06